[CTXR] QoQ Quarter Result on 31-Mar-2022 [#Q2]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q2]
Profit Trend
QoQ- 18.36%
YoY- -82.70%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -3,450 -7,415 -8,864 -7,561 -9,225 -4,961 -5,824 -29.39%
Tax 144 576 -53 -30 34 167 63 73.25%
NP -3,594 -7,991 -8,811 -7,531 -9,225 -4,961 -5,824 -27.45%
Tax Rate - - - - - - - -
Total Cost 3,594 7,991 8,811 7,531 9,225 4,961 5,824 -27.45%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.02 -0.05 -0.06 -0.05 -0.06 -0.03 -0.04 -36.92%
EPS Diluted -0.02 -0.05 -0.06 -0.05 -0.06 -0.03 -0.04 -36.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.